Skip to main content
All lobbying filings

KERRY INC. AND AFFILIATES OWNED BY KERRY HOLDING CO INCLUDING NIACET CORPORATION

Lobbying for KERRY INC. AND AFFILIATES OWNED BY KERRY HOLDING CO INCLUDING NIACET CORPORATION · Kerry is a world leader in sustainable taste and nutrition solutions.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Wisconsin · House · Senate · $160,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 9
 Lobbying activity 6
Environment/Superfund

Engaged with federal lawmakers on the PACK Act (HR 6832) in the House and Senate.

Food Industry (safety, labeling, etc.)

Engaged with federal policymakers and regulatory agencies on matters related to food ingredient policy - potential GRAS modernisation and uniform regulation. Discussed the Better Food Disclosure Act of 2025 (S. 3122), Ensuring Safe and Toxic Free Foods Act of 2025 (S. 2341), Grocery Reform and Safety Act (HR 4958) and the FDA Review for Safe, Healthy and Affordable Foods Act draft. Also advocated in support of the CURD Act (S. 184/HR 1394), and The DAIRY PRIDE Act (S. 2507). Discussed the need for science based regulations and legislation in food regulation. Engaged with FDA to discuss proposed two-tier inspection system, and to discuss supplements related regulatory issues

Agriculture

Engaged with federal legislators and agencies on the benefits of sustainable farming practices. Discussed Dairy Business Innovation Initiative funding, reauthorization of the Dairy Forward pricing program, allowing whole and 2% milk in school nutrition programs, and maintaining a strong SNAP program.

Trade (domestic/foreign)

Engaged on U.S. trade policy issues related to tariffs and market access, including the impact of existing and proposed tariff measures.

Health Issues

Discussed making dietary supplements eligible for HAS/FSA reimbursement. Discussed benefits of HR 7366, the Dietary Supplement Regulatory Uniformity Act. Also raised the need for mondernizing the Dietary Supplement Health & education Act of 1994.

Science/Technology

Engaged federal lawmakers on the CHIPs Act and Biotechnology, including recommendations from the National Security Commission on Emerging Biotechnology and the National Biotech Initiative Act of 2025, S. 1387

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem